
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7168972
[patent_doc_number] => 20040077560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Injectable ready-to-use solutions containing an antitumor anthracycline glycoside'
[patent_app_type] => new
[patent_app_number] => 10/455999
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11834
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077560.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455999
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455999 | Injectable ready-to-use solutions containing an antitumor anthracycline glycoside | Nov 23, 2003 | Abandoned |
Array
(
[id] => 7405428
[patent_doc_number] => 20040105838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Orlistat compositions'
[patent_app_type] => new
[patent_app_number] => 10/718049
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7146
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20040105838.pdf
[firstpage_image] =>[orig_patent_app_number] => 10718049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/718049 | Orlistat compositions | Nov 19, 2003 | Abandoned |
Array
(
[id] => 701701
[patent_doc_number] => 07064110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-20
[patent_title] => '6-11 bicycle ketolide derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/717290
[patent_app_country] => US
[patent_app_date] => 2003-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50862
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/064/07064110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10717290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/717290 | 6-11 bicycle ketolide derivatives | Nov 18, 2003 | Issued |
Array
(
[id] => 7168962
[patent_doc_number] => 20040077557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Macrolide antibiotics'
[patent_app_type] => new
[patent_app_number] => 10/450893
[patent_app_country] => US
[patent_app_date] => 2003-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82637
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077557.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450893
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450893 | Macrolide antibiotics | Nov 18, 2003 | Abandoned |
Array
(
[id] => 7435907
[patent_doc_number] => 20040266833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Novel use of certain insulin sensitizers or ppar-gamma agonists'
[patent_app_type] => new
[patent_app_number] => 10/416599
[patent_app_country] => US
[patent_app_date] => 2003-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3194
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266833.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416599
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416599 | Novel use of certain insulin sensitizers or ppar-gamma agonists | Nov 17, 2003 | Abandoned |
Array
(
[id] => 7452950
[patent_doc_number] => 20040067898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Synthesis and separation of optically active isomers of erythromycin and their biological actions'
[patent_app_type] => new
[patent_app_number] => 10/432913
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9317
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067898.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432913
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432913 | Synthesis and separation of optically active isomers of erythromycin and their biological actions | Nov 16, 2003 | Abandoned |
Array
(
[id] => 1009413
[patent_doc_number] => 06900175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => 'Methods of administering dalbavancin for treatment of bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 10/714261
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22928
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900175.pdf
[firstpage_image] =>[orig_patent_app_number] => 10714261
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/714261 | Methods of administering dalbavancin for treatment of bacterial infections | Nov 13, 2003 | Issued |
Array
(
[id] => 7098450
[patent_doc_number] => 20050130909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Dalbavancin compositions for treatment of bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 10/714166
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24537
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130909.pdf
[firstpage_image] =>[orig_patent_app_number] => 10714166
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/714166 | Dalbavancin compositions for treatment of bacterial infections | Nov 13, 2003 | Abandoned |
Array
(
[id] => 7061649
[patent_doc_number] => 20050004011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Compositions and methods for treating bacterial infections with protein-dalbavancin complexes'
[patent_app_type] => utility
[patent_app_number] => 10/713924
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 25567
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10713924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/713924 | Compositions and methods for treating bacterial infections with protein-dalbavancin complexes | Nov 13, 2003 | Abandoned |
Array
(
[id] => 7305873
[patent_doc_number] => 20040116334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Antibiotics AA-896'
[patent_app_type] => new
[patent_app_number] => 10/713881
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10813
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10713881
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/713881 | Antibiotics AA-896 | Nov 13, 2003 | Issued |
Array
(
[id] => 6991396
[patent_doc_number] => 20050090433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Dalbavancin compositions for treatment of bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 10/493558
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24713
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090433.pdf
[firstpage_image] =>[orig_patent_app_number] => 10493558
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/493558 | Dalbavancin compositions for treatment of bacterial infections | Nov 13, 2003 | Abandoned |
Array
(
[id] => 7474080
[patent_doc_number] => 20040097435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Method of treating parasitic infection'
[patent_app_type] => new
[patent_app_number] => 10/712871
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3099
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097435.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712871 | Method of treating parasitic infection | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7288051
[patent_doc_number] => 20040147461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Motilide compounds'
[patent_app_type] => new
[patent_app_number] => 10/712632
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16885
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147461.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712632
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712632 | Motilide compounds | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7677164
[patent_doc_number] => 20040152662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Method for preventing, reducing, and treating radiation cystitis using hyaluronic acid'
[patent_app_type] => new
[patent_app_number] => 10/705255
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5490
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152662.pdf
[firstpage_image] =>[orig_patent_app_number] => 10705255
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/705255 | Method for preventing, reducing, and treating radiation cystitis using hyaluronic acid | Nov 9, 2003 | Abandoned |
Array
(
[id] => 5028909
[patent_doc_number] => 20070270356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Substituted 9A-N-[N\'-(Benzenesulfonyl)Carbamoyl-Y-Aminopropyl] and 9A-N-[N\'(B-Cyanoethyl)-N\'-(Benzenesulfonyl)Carbamoyl-Y-Aminopropyl]Derivatives of 9-Deoxo-9-Dihydro-9A-Aza-9A-Homoerithomycin A'
[patent_app_type] => utility
[patent_app_number] => 10/534261
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4778
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270356.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534261
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534261 | Substituted 9A-N-[N'-(Benzenesulfonyl)Carbamoyl-Y-Aminopropyl] and 9A-N-[N'(B-Cyanoethyl)-N'-(Benzenesulfonyl)Carbamoyl-Y-Aminopropyl]Derivatives of 9-Deoxo-9-Dihydro-9A-Aza-9A-Homoerithomycin A | Nov 9, 2003 | Abandoned |
Array
(
[id] => 5815260
[patent_doc_number] => 20060084795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Substituted 9a-n-[n\'-(benzenesulfonyl)carbamoyl-aminopropyl]and 9a-n-[n\'-(b-cya-neothyl) -n-[n\'-(benzenesulfonyl)carbamoyl-y-aminopropyl]derivatives of 9-deoxo-9-dihydro-9a-aza- 9a-homoerithromycin a and 5-0-aza-homoerithronolide a'
[patent_app_type] => utility
[patent_app_number] => 10/534628
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4047
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534628 | Substituted 9a-N-(N′-(sulfonyl)phenylcarbamoyl)derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithomycin A and 5-0-desosaminyl-9-deoxo-9-dihydro-9-a-aza-9a-homoerithronolide A | Nov 9, 2003 | Issued |
Array
(
[id] => 5842133
[patent_doc_number] => 20060120985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Novel ampiphilic derivatives of alpha-c-phenyl-n-tert-butyl nitrone'
[patent_app_type] => utility
[patent_app_number] => 10/533982
[patent_app_country] => US
[patent_app_date] => 2003-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13516
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20060120985.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533982
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533982 | Amphiphilic derivatives of α-C-phenyl-N-tert-butylnitrone | Nov 6, 2003 | Issued |
Array
(
[id] => 6906152
[patent_doc_number] => 20050101547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Stabilized azithromycin composition'
[patent_app_type] => utility
[patent_app_number] => 10/702690
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3541
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101547.pdf
[firstpage_image] =>[orig_patent_app_number] => 10702690
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/702690 | Stabilized azithromycin composition | Nov 5, 2003 | Abandoned |
Array
(
[id] => 7150944
[patent_doc_number] => 20040171570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation'
[patent_app_type] => new
[patent_app_number] => 10/701285
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 37902
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171570.pdf
[firstpage_image] =>[orig_patent_app_number] => 10701285
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/701285 | Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation | Nov 3, 2003 | Issued |
Array
(
[id] => 7677194
[patent_doc_number] => 20040152632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome'
[patent_app_type] => new
[patent_app_number] => 10/700650
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11601
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152632.pdf
[firstpage_image] =>[orig_patent_app_number] => 10700650
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/700650 | Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome | Nov 3, 2003 | Abandoned |